Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd

<< Previous

Bullboard Posts

Next >>

Post by biggdoggon Dec 25, 2024 1:27am

153 Views

Post# 36377079

C60

Their starter molecule C60, is not toxic, that's a huge positive. The vanadium is trapped inside the molecule and can't interact with cells? That's another big positive.

I found this video. https://youtu.be/OX3nL_LoWJs?si=4gYDlUEdceT43ycx

I think i am going to buy some c60 in olive oil. Interesting that they put 0.8mg/l to 1.5 mg/l in the oil. https://c360health.com/ Voyageur cost for fullerene is a royalty. If they get this segment moving forward for MRI and CT, it will be huge for market cap. Merry Christmas

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide